BiotechTube

Attention Deficit Hyperactivity Disorder

7 competing products in clinical development for Attention Deficit Hyperactivity Disorder.

Pipeline by Phase

Phase 2/31
Phase 32
Approved4

All Products (7)

ProductCompanyStageStatusHype
Atomoxetine HydrochlorideEli LillyApprovedCompleted
43
AtomoxetineEli LillyApprovedCompleted
43
Atomoxetine hydrochloride + PlaceboEli LillyApprovedCompleted
43
AtomoxetineEli LillyPhase 3Completed
40
CLONICEL (Clonidine HCl sustained release)ShionogiPhase 3Completed
40
Atomoxetine + PlaceboEli LillyPhase 2/3Completed
38
AtomoxetineEli LillyApprovedTerminated
35